<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EF77BFB6-C66E-441F-AFE3-94353782E01C"><gtr:id>EF77BFB6-C66E-441F-AFE3-94353782E01C</gtr:id><gtr:name>University of Tokyo</gtr:name><gtr:address><gtr:line1>University of Tokyo</gtr:line1><gtr:line2>Bunkyo-Ku</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A62F2260-6B49-42BE-B708-669A800FA05C"><gtr:id>A62F2260-6B49-42BE-B708-669A800FA05C</gtr:id><gtr:name>German Rheumatism Research Centre (DRFZ)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE0A6EFE-F5FF-4B1D-A2C6-C1E6DEB6B1CC"><gtr:id>AE0A6EFE-F5FF-4B1D-A2C6-C1E6DEB6B1CC</gtr:id><gtr:name>Johannes Gutenberg University of Mainz</gtr:name><gtr:address><gtr:line1>University of Mainz</gtr:line1><gtr:line4>Mainz</gtr:line4><gtr:postCode>D-55099</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EF77BFB6-C66E-441F-AFE3-94353782E01C"><gtr:id>EF77BFB6-C66E-441F-AFE3-94353782E01C</gtr:id><gtr:name>University of Tokyo</gtr:name><gtr:address><gtr:line1>University of Tokyo</gtr:line1><gtr:line2>Bunkyo-Ku</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A62F2260-6B49-42BE-B708-669A800FA05C"><gtr:id>A62F2260-6B49-42BE-B708-669A800FA05C</gtr:id><gtr:name>German Rheumatism Research Centre (DRFZ)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE0A6EFE-F5FF-4B1D-A2C6-C1E6DEB6B1CC"><gtr:id>AE0A6EFE-F5FF-4B1D-A2C6-C1E6DEB6B1CC</gtr:id><gtr:name>Johannes Gutenberg University of Mainz</gtr:name><gtr:address><gtr:line1>University of Mainz</gtr:line1><gtr:line4>Mainz</gtr:line4><gtr:postCode>D-55099</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/FDF8C76C-8825-40D1-BBD6-BFBDF5E5555C"><gtr:id>FDF8C76C-8825-40D1-BBD6-BFBDF5E5555C</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Anderton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C567C858-C3B2-43FB-BA28-EE022C38B6C9"><gtr:id>C567C858-C3B2-43FB-BA28-EE022C38B6C9</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Anthony</gtr:otherNames><gtr:surname>O Connor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801924"><gtr:id>73A583C3-9FD7-43D3-B840-492A3037E4F1</gtr:id><gtr:title>Immune cell interactions in the Inflamed CNS</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801924</gtr:grantReference><gtr:abstractText>Around 80,000 people in the UK suffer from multiple sclerosis (MS). Although the precise mechanism that underlie this disease are still poorly understood, there is a consensus that in its early stages there is an ?autoimmune? attack on the brain with immune cells causing inflammation that ultimately destroys the nerves. From a mouse model of MS, called EAE, we know that CD4+ T cells are important both in the development of the disease and in the recovery from disease that can occur. Two types of CD4+ T cells are involved in promoting EAE, so-called Th1 and Th17 cells, and a third type ? T regulatory (Treg) cells are involved in recovery. However, we do not know how these three populations interact during the disease. We have developed new EAE models that allow us to identify and track each cell population within the brain, to determine whether Th1 and Th17 cells work together, independently, or perhaps even against each other to cause the disease. The models will also show how Treg cells can stop the damage caused by Th1 and Th17 cells and will allow us to develop new therapeutic approaches to boost Treg activity. These will also be tested for the ability to promote the repair of damaged nerves. We will also search for new ?biomarkers? which might indicate whether the disease will progress or will recover, and which could be used to better predict the course of MS in patients.</gtr:abstractText><gtr:technicalSummary>CD4+ T cells have a powerful capacity to either promote or restrain autoimmune inflammation. Classically Th1 cells, characterized by the production of IFN-gamma, were believed to drive inflammation in most autoimmune diseases, but recent evidence (largely from gene knockout studies) has given rise to the belief that such inflammatory diseases are driven primarily by the actions of IL-17-producing Th17 cells. CD4+ T regulatory (Treg) cells expressing the foxp3 transcription factor have a key role in preventing widespread autoimmune disease. Moreover, Th1 cells are believed to suppress generation of Th17 cells, based on studies of in vitro differentiation from na?ve T cells. So far there has been no methodical analysis of how effector cells (Th1 and Th17) and Treg cells interact within an inflamed organ. We have begun to define this using murine experimental autoimmune encephalomyelitis (EAE), the primary pre-clinical model for multiple sclerosis. Using distinguishable Th1, Th17 and Treg populations we have recently shown that a) Th1 cells preferentially access the non-inflamed CNS to initiate the EAE lesion; b) this allows Th17 and Treg cells to enter the inflamed CNS; c) the action of Tregs within the CNS is essential in driving disease resolution and d) therapeutic administration of myelin-responsive Tregs can be curative in ongoing chronic EAE models.
 In this project we will use traceable populations to determine precisely how these three CD4+ T cell populations influence each other in vitro and during inflammation in vivo. We will determine the basis for the Th1 cells? preferential access to the non-inflamed CNS and how they make the CNS accessible to other cells. We will investigate how Th1 and Th17 effector cells influence the function of each other in the CNS. We have established a novel in vitro assay system that is providing evidence for surprising synergistic, rather than antagonistic effects between Th1 and Th17 cells and these will now be explored in vivo. Finally we will test a novel model for Treg function in vivo, determine whether their effects can promote remyelination in EAE and assess whether the presence of foxp3+ cells correlates with remyelination in MS lesions. This project aims to give the most complete picture of the natural history of EAE as a model autoimmune disease. It will provide a basis for the informed development of novel therapeutics and should provide new biomarkers for disease phenotype, progression and resolution.</gtr:technicalSummary><gtr:fund><gtr:end>2014-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1462889</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Cellular and Molecular Medicine</gtr:department><gtr:description>Immune tolerance and autoimmune disease - T cells</gtr:description><gtr:id>956CF698-9072-4CD4-8B6C-0AD13F849880</gtr:id><gtr:impact>Publications:-
PMID: 18768826</gtr:impact><gtr:partnerContribution>Exchange of data and ideas relating to immune tolerance and the nature of pathogenic T cells in CNS autoimmune disease</gtr:partnerContribution><gtr:piContribution>Exchange of data and ideas relating to immune tolerance and the nature of pathogenic T cells in CNS autoimmune disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tokyo</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Antibodies for T cell tolerance</gtr:description><gtr:id>AF2A8DE9-F8BB-4DF8-843F-2B89BB459CB3</gtr:id><gtr:impact>Manuscript in press</gtr:impact><gtr:partnerContribution>Provision of antibodies for immune tolerance studies</gtr:partnerContribution><gtr:piContribution>Expertise in peptide-induced immune tolerance</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Johannes Gutenberg University of Mainz</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>T cells and B cells in immune tolerance</gtr:description><gtr:id>F44057D8-ECBC-4A86-AD23-AC782D94F874</gtr:id><gtr:impact>PMID 18832734 and manuscript in press</gtr:impact><gtr:partnerContribution>Enhanced understanding of immune tolerance</gtr:partnerContribution><gtr:piContribution>Provision of anti CD25 antibody, expertise in EAE and peptide-induced immune toleance</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Immunology and Infection Research</gtr:department><gtr:description>DC function</gtr:description><gtr:id>0C4DA7D6-2E60-46A2-960D-01D675DEBE6B</gtr:id><gtr:impact>PMID 19234175</gtr:impact><gtr:partnerContribution>Improved understanding of DC biology in EAE</gtr:partnerContribution><gtr:piContribution>Expertise in T cell differentiation / EAE</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>German Rheumatism Research Centre (DRFZ)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Immunology; German Rheumatism Research Centre(DRFZ)</gtr:department><gtr:description>Immune tolerance and autoimmune disease - B cells</gtr:description><gtr:id>594FEED9-B79A-4770-9A47-5336956B1BC7</gtr:id><gtr:impact>PMID: 18772002 
PMID: 18437156
PMID: 18354200
PMID: 20477161
PMID: 16506290</gtr:impact><gtr:partnerContribution>Exchange of data and ideas relating to B cell function in CNS autoimmune disease</gtr:partnerContribution><gtr:piContribution>Exchange of data and ideas related to B cell function in autoimmune disease</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leibniz Association</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Rheumatism Research Centre (DRFZ)</gtr:department><gtr:description>B cells in autoimmune disease</gtr:description><gtr:id>2CC0D39F-6D40-4260-A437-FD33B2BF3FBF</gtr:id><gtr:impact>PMID 16506290, 18354200, 18772002, 18437156, 19037227</gtr:impact><gtr:partnerContribution>Multiple interactions on T cell and B cell biology</gtr:partnerContribution><gtr:piContribution>Expertise in EAE and T cell biology/tolerance</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Immunology and Infection Research</gtr:department><gtr:description>Antigen presenting cells</gtr:description><gtr:id>564A6558-3FE4-4570-AD86-84D76E56A83F</gtr:id><gtr:impact>PMID: 20819926 
PMID: 19234175</gtr:impact><gtr:partnerContribution>Exchange of data, reagents and ideas relating to antigen presenting cell function</gtr:partnerContribution><gtr:piContribution>Exchange of data, reagents and ideas relating to antigen presenting cell function</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University School of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection and Immunity</gtr:department><gtr:description>IL-6 in autoimmune disease</gtr:description><gtr:id>C57BA5C6-C18F-468A-85FB-C37403D27188</gtr:id><gtr:impact>PMID:22547654</gtr:impact><gtr:partnerContribution>Exchange of ideas, reagents and data relevant to the role of IL-6 in CNS autoimmune disease</gtr:partnerContribution><gtr:piContribution>Exchange of ideas, reagents and data relevant to the role of IL-6 in CNS autoimmune disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Johannes Gutenberg University of Mainz</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>CNS autoimmune disease</gtr:description><gtr:id>32C50B1E-6797-45C0-A6E2-1923F7FCE900</gtr:id><gtr:impact>PMID: 18832734
PMID: 20113370</gtr:impact><gtr:partnerContribution>Exchange of data and ideas relating to mechanisms of immune tolerance</gtr:partnerContribution><gtr:piContribution>Exchenge of data and ideas relating to mechanisms of immune tolerance</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>Immune tolerance in allergic airways disease</gtr:description><gtr:id>2E613C35-642B-414E-9FC6-B4A50CA82C20</gtr:id><gtr:impact>Award of MRC CTF - ongoing</gtr:impact><gtr:partnerContribution>Expertise in allergic airways disease</gtr:partnerContribution><gtr:piContribution>Expertise in peptide-induced immune tolerance</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>Epigenetics of Immune Tolerance</gtr:description><gtr:id>0232E913-834E-401F-BBF9-42E1AB5FAF61</gtr:id><gtr:impact>Major part of application for renewal of G0801924</gtr:impact><gtr:partnerContribution>Epigenetic analyses of tolerant T cells</gtr:partnerContribution><gtr:piContribution>Advancing our understanding of the molecular mechanisms of therapeutic immune tolerance</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Cellular and Molecular Medicine</gtr:department><gtr:description>T cell function in EAE</gtr:description><gtr:id>67687FEE-35F2-4DF1-BE31-E6D5A326B869</gtr:id><gtr:impact>PMID 18768826</gtr:impact><gtr:partnerContribution>Improved understanding of T cell function in EAE</gtr:partnerContribution><gtr:piContribution>T cell differentiation / pathology studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Dutch MS Stichting Meet the Scientists</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5FF8AA0E-5799-4F6E-9A18-C4C888A9465B</gtr:id><gtr:impact>Patients Q@A session with the researcher

None as yet</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dutch MS Stichting Annual report</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C867118F-5E69-4202-98D9-508EC16D2B7E</gtr:id><gtr:impact>Science discussed in annual report; distributed to Dutch MS patients and hospitals

None as yet</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dutch MS Society Interview 2012</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>780FEF5C-16D7-4A19-B444-B9470765761B</gtr:id><gtr:impact>Interview for Dutch MS Society magazine.
Background to and aims of the project described

Describing our work to lay audience affected by MS</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh International Science Festival 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BF708689-0E68-46DE-9003-6524B58E7DB1</gtr:id><gtr:impact>Lab member involved in &amp;quot;Therapeutic Helminths&amp;quot; presentation

Continued involvement in Edinburgh Science Festival</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh International Science Festival 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2732D533-5D93-4851-B035-17EE945083CC</gtr:id><gtr:impact>Work in progress</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh International Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5E8F30EA-3DA1-47F4-A91D-54EFC14969A2</gtr:id><gtr:impact>3 lab members involved in &amp;quot;Mini-scientists&amp;quot; wokshop organized by MRC

Continued involvement in Edinburgh Science Festival</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>876851</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1100084</gtr:fundingRef><gtr:id>752A7710-39B6-4D33-8E0D-99CD0815A7F9</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1957180</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant (co-applicant with Prof J Iredale)</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J010766/1</gtr:fundingRef><gtr:id>CD8ECF2D-4010-4C5F-809F-3D02198ABC05</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>929534</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Intermediate Fellowship (Awarded to Dr R. Mellanby)</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>098493</gtr:fundingRef><gtr:id>4CD364E8-62EE-41F1-8D6F-621FAD670052</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>201657</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Chief Scientist Office (CSO)</gtr:department><gtr:description>Project Grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Scottish Government</gtr:fundingOrg><gtr:fundingRef>ETM/163</gtr:fundingRef><gtr:id>A715D8BA-1DCE-4390-8A0C-DDDF4CCF2867</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Aquila Biomedical Ltd</gtr:companyName><gtr:description>Small CRO offering access to model of action modelling across a range of disease areas.
www.Aquila-bm.com</gtr:description><gtr:id>A65AE83C-F6BC-403A-9DDD-736FFC6A78BD</gtr:id><gtr:impact>Too early</gtr:impact><gtr:url>http://www.aquila-bm.com/index.html</gtr:url><gtr:yearCompanyFormed>2011</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F5C8C75-6B39-4D35-B136-64B8DED80D0E"><gtr:id>0F5C8C75-6B39-4D35-B136-64B8DED80D0E</gtr:id><gtr:title>Thymus-Derived Regulatory T Cells Are Positively Selected on Natural Self-Antigen through Cognate Interactions of High Functional Avidity.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/34808c75f907fef5612f1ea28a149e5c"><gtr:id>34808c75f907fef5612f1ea28a149e5c</gtr:id><gtr:otherNames>Kieback E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/391AD6A6-03FA-4892-9362-72EDCB1813A1"><gtr:id>391AD6A6-03FA-4892-9362-72EDCB1813A1</gtr:id><gtr:title>Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8717456a0d977976c926cece73eef386"><gtr:id>8717456a0d977976c926cece73eef386</gtr:id><gtr:otherNames>Reynolds BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A4C2A30F-3A34-4EE0-B918-1AA02D6969B1"><gtr:id>A4C2A30F-3A34-4EE0-B918-1AA02D6969B1</gtr:id><gtr:title>RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e56a64f6ec151718f0535c9ad1899168"><gtr:id>e56a64f6ec151718f0535c9ad1899168</gtr:id><gtr:otherNames>Astier AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C993A867-A216-44FD-A8BF-4833F6D1B69A"><gtr:id>C993A867-A216-44FD-A8BF-4833F6D1B69A</gtr:id><gtr:title>Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4e76615cc778430bf81c2ff45fd04cb"><gtr:id>b4e76615cc778430bf81c2ff45fd04cb</gtr:id><gtr:otherNames>McPherson RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B1905D0-0224-4E23-A305-2D2A53B49F1B"><gtr:id>7B1905D0-0224-4E23-A305-2D2A53B49F1B</gtr:id><gtr:title>B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c69552d568427db812244f92bb1161cf"><gtr:id>c69552d568427db812244f92bb1161cf</gtr:id><gtr:otherNames>Barr TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9AAF8A89-D8F4-4E61-B49E-3685A2F4005F"><gtr:id>9AAF8A89-D8F4-4E61-B49E-3685A2F4005F</gtr:id><gtr:title>Activated T cells recruit exosomes secreted by dendritic cells via LFA-1.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/720d589cd5ec4040ecdbc3b3c8f44e35"><gtr:id>720d589cd5ec4040ecdbc3b3c8f44e35</gtr:id><gtr:otherNames>Nolte-'t Hoen EN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5764BB9F-1F47-4451-A999-F51117EA9FF6"><gtr:id>5764BB9F-1F47-4451-A999-F51117EA9FF6</gtr:id><gtr:title>IL-10-producing, ST2-expressing Foxp3(+) T cells in multiple sclerosis brain lesions.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9034ac8a70308a688c496621c2914424"><gtr:id>9034ac8a70308a688c496621c2914424</gtr:id><gtr:otherNames>Zandee SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE42E149-9834-4023-B6FB-BC0D42B5C583"><gtr:id>DE42E149-9834-4023-B6FB-BC0D42B5C583</gtr:id><gtr:title>Myelin-reactive, TGF-?-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87b677d4d98cbb244cc46a69c9bbb7d6"><gtr:id>87b677d4d98cbb244cc46a69c9bbb7d6</gtr:id><gtr:otherNames>O'Connor RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67DC6FF6-22CD-4495-9DA8-EAB8EE04B2D5"><gtr:id>67DC6FF6-22CD-4495-9DA8-EAB8EE04B2D5</gtr:id><gtr:title>Activation of CD4? Foxp3? regulatory T cells proceeds normally in the absence of B cells during EAE.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70e822702587b3b74bf719bf85b2775e"><gtr:id>70e822702587b3b74bf719bf85b2775e</gtr:id><gtr:otherNames>Hoehlig K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C906E142-AF4B-4B62-889C-166E0C5168C7"><gtr:id>C906E142-AF4B-4B62-889C-166E0C5168C7</gtr:id><gtr:title>Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7208301cc7406871f5fedefa787324ef"><gtr:id>7208301cc7406871f5fedefa787324ef</gtr:id><gtr:otherNames>Wilson MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8F9F4FEB-0465-4697-B513-D3699C13EE15"><gtr:id>8F9F4FEB-0465-4697-B513-D3699C13EE15</gtr:id><gtr:title>T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87b677d4d98cbb244cc46a69c9bbb7d6"><gtr:id>87b677d4d98cbb244cc46a69c9bbb7d6</gtr:id><gtr:otherNames>O'Connor RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD7DADE4-DA53-45BE-89C0-F2BA33E8651D"><gtr:id>AD7DADE4-DA53-45BE-89C0-F2BA33E8651D</gtr:id><gtr:title>Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3ff6ebd6b6261e1b34760ccb07c464"><gtr:id>ba3ff6ebd6b6261e1b34760ccb07c464</gtr:id><gtr:otherNames>Leech MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E9FC12C-EDF7-4423-9D7C-DEA0949442D6"><gtr:id>8E9FC12C-EDF7-4423-9D7C-DEA0949442D6</gtr:id><gtr:title>Acute Liver Injury Is Independent of B Cells or Immunoglobulin M.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ab49ebeb9feadd3306d3b8ffe4135724"><gtr:id>ab49ebeb9feadd3306d3b8ffe4135724</gtr:id><gtr:otherNames>Richards JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E408BA48-3D5F-430E-893F-0A7A9E832DBB"><gtr:id>E408BA48-3D5F-430E-893F-0A7A9E832DBB</gtr:id><gtr:title>Bystander suppression of experimental arthritis by nasal administration of a heat shock protein peptide.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25c3b12a1e73fcc9fbc704238c21f410"><gtr:id>25c3b12a1e73fcc9fbc704238c21f410</gtr:id><gtr:otherNames>Zonneveld-Huijssoon E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1350C03C-A6AD-40EF-AAC3-A618D4B8E208"><gtr:id>1350C03C-A6AD-40EF-AAC3-A618D4B8E208</gtr:id><gtr:title>Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8f33910d5efa90725bba8046dcd81752"><gtr:id>8f33910d5efa90725bba8046dcd81752</gtr:id><gtr:otherNames>Carrillo-Vico A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F3D8A26-1302-44E9-900A-6DFE32DA82F2"><gtr:id>4F3D8A26-1302-44E9-900A-6DFE32DA82F2</gtr:id><gtr:title>Foxp3? Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87b677d4d98cbb244cc46a69c9bbb7d6"><gtr:id>87b677d4d98cbb244cc46a69c9bbb7d6</gtr:id><gtr:otherNames>O'Connor RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/772F0AB6-E16E-4DCA-ABF9-BE852F1FB804"><gtr:id>772F0AB6-E16E-4DCA-ABF9-BE852F1FB804</gtr:id><gtr:title>Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8? T cells derived from autoantigen-deficient mice.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba3ff6ebd6b6261e1b34760ccb07c464"><gtr:id>ba3ff6ebd6b6261e1b34760ccb07c464</gtr:id><gtr:otherNames>Leech MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B665696F-4C8B-47F7-9CA1-488B5086E9D7"><gtr:id>B665696F-4C8B-47F7-9CA1-488B5086E9D7</gtr:id><gtr:title>A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3cc54abeeaeaa1e3ab5b35264e98e86f"><gtr:id>3cc54abeeaeaa1e3ab5b35264e98e86f</gtr:id><gtr:otherNames>Perona-Wright G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9DF2A66-49FB-40BC-B2B6-3D904F0E0C63"><gtr:id>E9DF2A66-49FB-40BC-B2B6-3D904F0E0C63</gtr:id><gtr:title>Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a6318beadc7fa9e50cd9a1503220dbc4"><gtr:id>a6318beadc7fa9e50cd9a1503220dbc4</gtr:id><gtr:otherNames>Calder?n-G?mez E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/314D7FD1-2707-484E-B093-84C2346B3A88"><gtr:id>314D7FD1-2707-484E-B093-84C2346B3A88</gtr:id><gtr:title>Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dd3a0646322fc1460814e83ec383a64b"><gtr:id>dd3a0646322fc1460814e83ec383a64b</gtr:id><gtr:otherNames>Lampropoulou V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/982C3F7D-9F30-42D7-8544-3956AE638B1A"><gtr:id>982C3F7D-9F30-42D7-8544-3956AE638B1A</gtr:id><gtr:title>Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87b677d4d98cbb244cc46a69c9bbb7d6"><gtr:id>87b677d4d98cbb244cc46a69c9bbb7d6</gtr:id><gtr:otherNames>O'Connor RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BAD76FF4-D17D-491C-92C1-F0CF319117FD"><gtr:id>BAD76FF4-D17D-491C-92C1-F0CF319117FD</gtr:id><gtr:title>Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ee9cf016bc01671d19df24289f6ca131"><gtr:id>ee9cf016bc01671d19df24289f6ca131</gtr:id><gtr:otherNames>Haines CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55CACC7A-D384-45E8-9872-391C6FD50EAA"><gtr:id>55CACC7A-D384-45E8-9872-391C6FD50EAA</gtr:id><gtr:title>Helminths and immunological tolerance.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f85868c6cbbecf6fc0ee47f670a042c3"><gtr:id>f85868c6cbbecf6fc0ee47f670a042c3</gtr:id><gtr:otherNames>Johnston CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C28BF2EB-DD92-4192-9E6A-21449059F849"><gtr:id>C28BF2EB-DD92-4192-9E6A-21449059F849</gtr:id><gtr:title>Antigen-based immunotherapy (AIT) for autoimmune and allergic disease.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cabf9779147551945b5c5b457e27740a"><gtr:id>cabf9779147551945b5c5b457e27740a</gtr:id><gtr:otherNames>MacLeod MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A72A6D16-BC19-42F7-B49F-5A49C931AF68"><gtr:id>A72A6D16-BC19-42F7-B49F-5A49C931AF68</gtr:id><gtr:title>Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9ddeef048785c24be1113401aefff4e6"><gtr:id>9ddeef048785c24be1113401aefff4e6</gtr:id><gtr:otherNames>van Herwijnen MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B0009DAA-126F-4CC0-9E20-3BD9F57DB144"><gtr:id>B0009DAA-126F-4CC0-9E20-3BD9F57DB144</gtr:id><gtr:title>IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6aa1011d9efeb6a556d72153917cf8d7"><gtr:id>6aa1011d9efeb6a556d72153917cf8d7</gtr:id><gtr:otherNames>Shen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C0F77E4-E20A-421D-8603-34535BC76C29"><gtr:id>0C0F77E4-E20A-421D-8603-34535BC76C29</gtr:id><gtr:title>Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87b677d4d98cbb244cc46a69c9bbb7d6"><gtr:id>87b677d4d98cbb244cc46a69c9bbb7d6</gtr:id><gtr:otherNames>O'Connor RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/712DF1F2-C0D2-447F-BB23-1BCD062CCE95"><gtr:id>712DF1F2-C0D2-447F-BB23-1BCD062CCE95</gtr:id><gtr:title>Viral respiratory tract infections and asthma in early life: cause and effect?</gtr:title><gtr:parentPublicationTitle>Clinical &amp; Experimental Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4a8405cb54cbd31c9de963dde927852"><gtr:id>b4a8405cb54cbd31c9de963dde927852</gtr:id><gtr:otherNames>Mackenzie K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8545C0F7-33F9-4B19-81D0-5C059BEECBE6"><gtr:id>8545C0F7-33F9-4B19-81D0-5C059BEECBE6</gtr:id><gtr:title>1,25-Dihydroxyvitamin D3-Conditioned CD11c+ Dendritic Cells are Effective Initiators of CNS Autoimmune Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3bb7ce1d7b2d5786874dd68ab5ce536b"><gtr:id>3bb7ce1d7b2d5786874dd68ab5ce536b</gtr:id><gtr:otherNames>Besusso D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5994AA1F-8D59-4E7E-93E1-034EE6DC4127"><gtr:id>5994AA1F-8D59-4E7E-93E1-034EE6DC4127</gtr:id><gtr:title>Immune cell entry to central nervous system--current understanding and prospective therapeutic targets.</gtr:title><gtr:parentPublicationTitle>Endocrine, metabolic &amp; immune disorders drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d5beb43a5a33faca8ea817083ddd8fcb"><gtr:id>d5beb43a5a33faca8ea817083ddd8fcb</gtr:id><gtr:otherNames>Prendergast CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1871-5303</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/520518AF-A7F6-46D0-87C7-6EF68E7DDD37"><gtr:id>520518AF-A7F6-46D0-87C7-6EF68E7DDD37</gtr:id><gtr:title>Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ebdbfe56efad0c6e2fd309804a984d98"><gtr:id>ebdbfe56efad0c6e2fd309804a984d98</gtr:id><gtr:otherNames>Stephens LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C874B2D7-F2E0-46AA-9A89-ADAE26DA3C3B"><gtr:id>C874B2D7-F2E0-46AA-9A89-ADAE26DA3C3B</gtr:id><gtr:title>CD11c depletion severely disrupts Th2 induction and development in vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d77299519c18775375cf9d386acd7f40"><gtr:id>d77299519c18775375cf9d386acd7f40</gtr:id><gtr:otherNames>Phythian-Adams AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C789458-FF36-483D-B5A2-19E112175FD5"><gtr:id>4C789458-FF36-483D-B5A2-19E112175FD5</gtr:id><gtr:title>Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb72d348134f22f139629df79a577f4d"><gtr:id>eb72d348134f22f139629df79a577f4d</gtr:id><gtr:otherNames>Verhagen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B1EBDB4-C292-46BA-982A-368BF79329FD"><gtr:id>8B1EBDB4-C292-46BA-982A-368BF79329FD</gtr:id><gtr:title>Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities.</gtr:title><gtr:parentPublicationTitle>Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4e76615cc778430bf81c2ff45fd04cb"><gtr:id>b4e76615cc778430bf81c2ff45fd04cb</gtr:id><gtr:otherNames>McPherson RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1557-1890</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/33C39B3E-C42E-490D-9875-FD1385F81696"><gtr:id>33C39B3E-C42E-490D-9875-FD1385F81696</gtr:id><gtr:title>Induction of passive EAE using myelin-reactive CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4e76615cc778430bf81c2ff45fd04cb"><gtr:id>b4e76615cc778430bf81c2ff45fd04cb</gtr:id><gtr:otherNames>McPherson RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1B9D86E7-018A-4917-8D5E-0426C89CE114"><gtr:id>1B9D86E7-018A-4917-8D5E-0426C89CE114</gtr:id><gtr:title>PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f066630871439d23802e10f6b4c6ec7"><gtr:id>7f066630871439d23802e10f6b4c6ec7</gtr:id><gtr:otherNames>Konkel JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FDEBD637-3C2B-4677-8B5B-65257775E0F2"><gtr:id>FDEBD637-3C2B-4677-8B5B-65257775E0F2</gtr:id><gtr:title>Treg and T-effector cells in autoimmune CNS inflammation: a delicate balance, easily disturbed.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/376cc62daff5e5b9084b1bce4541554c"><gtr:id>376cc62daff5e5b9084b1bce4541554c</gtr:id><gtr:otherNames>Anderton SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA290787-B7B1-4E1E-A771-F8F5384C6588"><gtr:id>FA290787-B7B1-4E1E-A771-F8F5384C6588</gtr:id><gtr:title>T cells at the site of autoimmune inflammation show increased potential for trogocytosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bbf1a64aec677b05f76136aa09689110"><gtr:id>bbf1a64aec677b05f76136aa09689110</gtr:id><gtr:otherNames>Haastert B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8EBEA05F-A1FA-4A55-A9C7-1FD5AE90C400"><gtr:id>8EBEA05F-A1FA-4A55-A9C7-1FD5AE90C400</gtr:id><gtr:title>Peptide immunotherapy for childhood allergy - addressing translational challenges.</gtr:title><gtr:parentPublicationTitle>Clinical and translational allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cdb7873ab95bbdbd121d17277f61d31e"><gtr:id>cdb7873ab95bbdbd121d17277f61d31e</gtr:id><gtr:otherNames>Mackenzie KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2045-7022</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/28E57735-3372-46F5-AC59-ABBC1CB6E8C8"><gtr:id>28E57735-3372-46F5-AC59-ABBC1CB6E8C8</gtr:id><gtr:title>eLS</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03ab633e3a57975d9e0b550332b4a6f5"><gtr:id>03ab633e3a57975d9e0b550332b4a6f5</gtr:id><gtr:otherNames>Mair I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>9780470016176</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B68F6F17-AA0D-414C-A26F-F4256E85EAA8"><gtr:id>B68F6F17-AA0D-414C-A26F-F4256E85EAA8</gtr:id><gtr:title>Inflammation-associated genes: risks and benefits to Foxp3+ regulatory T-cell function.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87b677d4d98cbb244cc46a69c9bbb7d6"><gtr:id>87b677d4d98cbb244cc46a69c9bbb7d6</gtr:id><gtr:otherNames>O'Connor RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6E2312C-CECF-4759-AFEC-A70AD8A95E3C"><gtr:id>F6E2312C-CECF-4759-AFEC-A70AD8A95E3C</gtr:id><gtr:title>Peptide immunotherapy in experimental autoimmune encephalomyelitis.</gtr:title><gtr:parentPublicationTitle>Biomedical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/376cc62daff5e5b9084b1bce4541554c"><gtr:id>376cc62daff5e5b9084b1bce4541554c</gtr:id><gtr:otherNames>Anderton SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2319-4170</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23E73254-1B9D-49FF-BAA4-11E6F0DE53F4"><gtr:id>23E73254-1B9D-49FF-BAA4-11E6F0DE53F4</gtr:id><gtr:title>Ischemic preconditioning in the liver is independent of regulatory T cell activity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/358429590744fedcbb8c0669a5acd826"><gtr:id>358429590744fedcbb8c0669a5acd826</gtr:id><gtr:otherNames>Devey LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801924</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>